RecruitingNCT03320304

A Study to Assess Effectiveness and Efficiency of VNS Therapy in Patients With Difficult to Treat Depression.

This recruiting study focuses on depression and currently lists sites or participation links in Austria, Belgium, Germany, United Kingdom.

DepressionOtherOver 18 Years

In plain English

Key information made simple

This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand what a therapy or guided support program could change in day-to-day care and decision-making. For people living with Depression, the gap between what sounds good on paper and what works in daily life is often important. If the findings are useful, they could help future care become more targeted, practical, and easier to trust. Taking part helps build the evidence that can improve understanding and care for others over time.

What to expect

Your next step

The official record suggests in-person participation through a hospital, with sites including AKH Allgemeines Krankenhaus der Stadt Wien in Vienna, KU Leuven in Leuven, and Sozialstiftung Bamberg - Klinikum am Bruderwald in Bamberg. Participation appears to center on questionnaires, assessments, or follow-up information rather than a study treatment. The main fit is usually matching the main diagnosis and being able to understand the study and consent, while common reasons not to take part include other treatments that could interfere with the study. The official record does not list a trial phase, which usually means the study is focused on observation rather than testing a staged treatment.

Official source

Registry reference

This page links back to the public source record so people can verify details directly with the registry and research team.

If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.

Open source record

Interested?

Check my eligibility

Study reference: NCT03320304. Your email is the only field you need to provide here.

In practice

For you

Taking part may give access to a new approach being evaluated.

It requires regular visits and structured follow-up.

Requires travel, with in-person participation in Austria.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com